Cargando…
Nanotechnology applications in hematological malignancies (Review)
A major limitation to current cancer therapies is the development of therapy-related side-effects and dose limiting complications. Moreover, a better understanding of the biology of cancer cells and the mechanisms of resistance to therapy is rapidly developing. The translation of advanced knowledge...
Autores principales: | SAMIR, AHMED, ELGAMAL, BASMA M, GABR, HALA, SABAAWY, HATEM E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530900/ https://www.ncbi.nlm.nih.gov/pubmed/26134389 http://dx.doi.org/10.3892/or.2015.4100 |
Ejemplares similares
-
Development and application of nanomaterials, nanotechnology and nanomedicine for treating hematological malignancies
por: Li, Jinxin, et al.
Publicado: (2023) -
Genetic Heterogeneity and Clonal Evolution of Tumor Cells and their Impact on Precision Cancer Medicine
por: Sabaawy, Hatem E
Publicado: (2013) -
Systematic Review and Meta-Synthesis about Patients with Hematological Malignancy and Palliative Care
por: Alnaeem, Mohammad Minwer, et al.
Publicado: (2022) -
Minimally manipulated autologous adherent bone marrow cells (ABMCs): a promising cell therapy of spinal cord injury
por: Misra, Kamana, et al.
Publicado: (2015) -
Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine
por: Pamarthy, Sahithi, et al.
Publicado: (2021)